These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17613771)

  • 1. Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy.
    Zeidan A; Sham R; Shapiro J; Baratta A; Kouides P
    Leuk Lymphoma; 2007 Jul; 48(7):1410-3. PubMed ID: 17613771
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
    Drini M; Prichard PJ; Brown GJ; Macrae FA
    Med J Aust; 2008 Oct; 189(8):464-5. PubMed ID: 18928444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?
    Rosh JR; Gross T; Mamula P; Griffiths A; Hyams J
    Inflamm Bowel Dis; 2007 Aug; 13(8):1024-30. PubMed ID: 17480018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancytopenia in a Young Male Patient With Inflammatory Bowel Disease.
    Jansson-Knodell CL; Walker MJ; Fischer M
    Gastroenterology; 2021 Apr; 160(5):1483-1485. PubMed ID: 32777287
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease.
    Thayu M; Markowitz JE; Mamula P; Russo PA; Muinos WI; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):220-2. PubMed ID: 15699701
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
    Ochenrider MG; Patterson DJ; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
    Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
    Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab use and hepatosplenic T cell lymphoma: questions to be asked and lessons learned.
    Rosh JR; Oliva-Hemker M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):165-7. PubMed ID: 17255825
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update.
    Mackey AC; Green L; Leptak C; Avigan M
    J Pediatr Gastroenterol Nutr; 2009 Mar; 48(3):386-8. PubMed ID: 19274799
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
    van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
    World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree?
    Moran G; Dillon J; Green J
    Inflamm Bowel Dis; 2009 Sep; 15(9):1281-2. PubMed ID: 19067412
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?
    Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J
    Intern Med J; 2014 Mar; 44(3):287-90. PubMed ID: 24621284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
    Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic lymphoma presenting initially as hemophagocytic syndrome in a 21-year-old man with Crohn's disease: a case report and literature review.
    Côté-Daigneault J; Bernard EJ
    Can J Gastroenterol; 2011 Aug; 25(8):417-8. PubMed ID: 21912765
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.
    Selvaraj SA; Chairez E; Wilson LM; Lazarev M; Bass EB; Hutfless S
    Syst Rev; 2013 Jul; 2():53. PubMed ID: 23826928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomas in two IBD patients treated with anti-TNF-α mono or combination therapy: is hepatosplenic lymphoma really the "old maid"?
    Molnár T; Farkas K; Nagy F; Szepes Z; Wittmann T
    Inflamm Bowel Dis; 2011 Sep; 17(9):2025-6. PubMed ID: 21290481
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
    Thai A; Prindiville T
    J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis.
    Brinkert F; Arrenberg P; Krech T; Grabhorn E; Lohse A; Schramm C
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27516526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
    Kotlyar DS; Osterman MT; Diamond RH; Porter D; Blonski WC; Wasik M; Sampat S; Mendizabal M; Lin MV; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):36-41.e1. PubMed ID: 20888436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease.
    Burger DC; Florin TH
    Med J Aust; 2009 Mar; 190(6):341-2. PubMed ID: 19296822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.